Pre-Market Breakout Alert

PRE-MARKET BREAKOUT ALERT

New Today: AZ Expands Its Retail Media Business as $195M+ in Backlog Puts it on the Radar

AZ Repeat Orders Are Accelerating the Growth Story

An $84M customer commitment, $195M+ contracted backlog and a $30 Wall Street target put this smart-cart company on the radar

PRE-MARKET BREAKOUT ALERT

JUNS Runs 68% as HOWL Jumps 54% Following Today’s Alerts

Both stocks delivered strong moves after this morning’s pre-market alerts

PRE-MARKET BREAKOUT ALERT

MYSZ Is Moving This Morning

MYSZ the AI Revenue Stream to Watch

Behind the surge sits an AI-driven SaaS business generating an 86% gross margin

New post

GRML Hits Two Key Milestones at Skaergaard

New marine data and drilling progress move the 2026 Skaergaard program deeper into execution

The Drills Are Turning on a $68 Billion Mineral Giant

With drilling underway and precious-metal prices surging, GRML’s $68 Billion Greenland mineral story is entering a pivotal phase

Investing.com Technical Opinion Rating Issued ASTC a Bullish STRONG BUY Rating

ASTC: A Major NASA Catalyst Ahead

A $20M proposal, lunar resources and a tight float set the stage

ASTC: A Lunar Strategy With a Major Catalyst Ahead

A $20M NASA proposal, lunar resources and a tight float put ASTC on the radar

Wall Street Sees $30 Potential in This AI Stock

A $195M+ backlog is only part of the story

FDA Clears the Path: MODD's Next-Gen Insulin Pump Hits the Market

With FDA clearance secured, Modular Medical is entering the commercial phase that could define its long-term growth trajectory.

Today's Trade Recap: +371%, +177% & +29%

EUDA Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness

Stem Cells, AI, Longevity, Small Float... & $55 Price Target!

Stem Cells, AI, Longevity... And A Small Float!

DFNS +434%, BIYA +149%, and INLF +139% from our alerts

Market Recap: +149% GAINS Today

Wall Street Analyst Initiates Coverage With Outperform Rating and $10 Price Target

Wall Street Analyst Initiated Coverage With an Outperform Rating and a $10 Price Target